IRIS International, Inc. (IRIS)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: LABORATORY ANALYTICAL INSTRUMENTS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

9158 ETON AVENUE CHATSWORTH, CA 91311

IRIS International is a manufacturer of automated in vitro diagnostic systems, sample processing products and personalized diagnostics tests for use in hospitals and laboratories. Co. consists of three operating units. The in vitro diagnostic segment, also called Iris Diagnostics Division, designs, manufactures and markets systems, consumables and supplies for urinalysis and body fluids. The Iris Sample Processing segment markets and develops centrifuges, deoxyribonucleic acid processing workstations and sample processing consumables. The Personalized Medicine segment combines the research and development operations of Iris Molecular Diagnostics and Co.'s laboratory, Arista Molecular, Inc.

View SEC Filings from IRIS instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding IRIS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IRIS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

YI JOHN U CORP VP, OPERATIONS

  • Officer
No longer subject to file 2012-10-31 0

GINSBURG PHILIP CORPORATE VP AND CMO

  • Officer
No longer subject to file 2012-10-31 0

ADAMS THOMAS PHD CTO & CORPORATE V.P.

  • Officer
No longer subject to file 2012-10-31 0

GARCIA CESAR M PRESIDENT AND CEO

  • Officer
  • Director
No longer subject to file 2012-10-31 0

MELLO ROBERT A CORP VP/PRES SAMPLE PROCESSING

  • Officer
No longer subject to file 2012-10-31 0

WAREKOIS TOM E CORP VP, PRES IRIS DIAGNOSTICS

  • Officer
No longer subject to file 2012-10-31 0

KHALIFA AMIN I CFO AND CORPORATE V.P. FINANCE

  • Officer
No longer subject to file 2012-10-31 0

O'LEARY RICHARD A. CORP. VP, HR & ADMIN

  • Officer
No longer subject to file 2012-10-31 0

DELLA PENTA DAVID T

  • Director
No longer subject to file 2012-10-31 0

TIMMINS RICK

  • Director
No longer subject to file 2012-10-31 0

VOBORIL EDWARD F

  • Director
No longer subject to file 2012-10-31 0

BESBECK STEVEN M

  • Director
No longer subject to file 2012-10-31 0

KARLAN BETH Y

  • Director
No longer subject to file 2012-10-31 0

WASSERMAN STEPHEN EDWARD

  • Director
No longer subject to file 2012-10-31 0

NADEAU RICHARD G

  • Director
31,346 2012-03-02 0

MATTE MICHAEL D

  • Director
24,592 2011-05-25 0

WHITE VANCE R CORP. VP, PRES.IRIS LAB DIV.

  • Officer
0 2010-07-28 0

MCDERMUT MARTIN S ACTING CHIEF FINANCIAL OFFICER

  • Officer
0 2010-05-11 0

DONATO PETER CORPORATE V.P. & C.F.O.

  • Officer
8,694 2010-05-04 0

WILLIAMS RICHARD H

  • Director
13,100 2008-12-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments